Avail Medsystems, the medical technology company pioneering telemedicine for the procedure room ("Procedural TelemedicineTM"), today announced that it has raised $100 million in Series B funding led by D1 Capital Partners, with participation from 8VC and existing investors. Avail previously raised $25 million in Series A and Series A-1 funding from investors including Lux Capital, Coatue, Sonder Capital, Playground Global, Baidu Ventures, and Refactor Capital.

The Avail System consists of a portable console used by surgeons in the operating room, paired with a versatile app for experts advising remotely on the procedure. The technology was developed over a three-year period by a team with more than 400 years of combined medical technology development, sales, and marketing experience. While a remarkable advance for care givers and patients, traditional telemedicine systems lack the capabilities needed in operating rooms when patients are at their most vulnerable. Avail's Procedural TelemedicineTM System is built specifically for the operating room and enables surgeons, outside experts, and the healthcare ecosystem to better serve patients by delivering the right knowledge, at the right time, to the right people.

Avail Medsystems is a pioneering medical technology company that removes the barriers of in-person medical procedure collaboration. With a customer-centric business model, Avail's purpose-built Procedural TelemedicineTM technology digitizes physical presence and enables on-the-go, HIPAA compliant collaboration among a network of healthcare professionals and industry experts.